Rapid Evaluation of Seasonal Influenza Vaccine

• Status: Withdrawn
• Trial end date: 2009-11-01
• Target enrollment: 0
• Participant gender: All

Summary

This is an invitation to consider taking part in a research study occurring just before the upcoming influenza vaccination program across Canada. The purpose of the study is to closely assess influenza vaccine safety and immune responses, as part of a nationwide, annual surveillance project sponsored by the Public Health Agency of Canada. Such scrutiny is important given the changing nature of flu vaccines from year to year.

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: University of British Columbia
• Treatments: Vaccines

Criteria

Inclusion Criteria:

Eligibility Inclusion:

• Good general health

• Written informed consent

• Adults 20-64 years of age

Exclusion Criteria:

• compromised immune system

• allergies to eggs or thimerosol

• life-threatening reaction to previous Flu vaccine

• chronic illness, bleeding disorder

any Flu vaccine within 6 mths planning any other vaccine during study